Emergence of ampicillin-resistant Enterococcus faecium in Danish hospitals

Camilla H Lester1, Dorthe Sandvang, Stefan S Olsen

  • 1Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark. cal@ssi.dk

Abstract

Insights

Ampicillin resistance in Enterococcus faecium is increasing in Denmark, with most resistant isolates belonging to clonal complex 17 (CC17). This highlights a growing challenge in hospital-acquired infections.

Area of Science:

  • Clinical microbiology
  • Infectious diseases
  • Epidemiology

Background:

  • Ampicillin-resistant Enterococcus faecium (E. faecium) is a growing concern in European hospitals.
  • Clonal complex 17 (CC17) is frequently associated with ampicillin resistance and hospital-acquired E. faecium infections globally.
  • Data on the prevalence and characteristics of ampicillin-resistant E. faecium in Denmark was limited.

Purpose of the Study:

  • To determine the prevalence of ampicillin resistance in clinical E. faecium isolates in Denmark.
  • To investigate the clonal affiliation of these resistant isolates, particularly their relationship to CC17.

Main Methods:

  • Analysis of microbiology data from Danish clinical laboratories (2002-2006).
  • Collection and analysis of 275 clinical enterococcal isolates from four departments (2004).
  • Multilocus sequence typing (MLST) and pulsed-field gel electrophoresis (PFGE) on 84 ampicillin-resistant E. faecium isolates.

Main Results:

  • A 68% increase in overall enterococcal infections was observed from 2002-2006, primarily driven by a tripling of E. faecium cases.
  • A significant rise in ampicillin-resistant E. faecium isolates was noted.
  • MLST revealed that 98% of ampicillin-resistant E. faecium isolates belonged to CC17, with PFGE indicating clonal spread within hospitals.

Conclusions:

  • Ampicillin-resistant E. faecium has significantly increased in Danish hospitals between 2002 and 2006.
  • The majority of these resistant isolates are associated with the CC17 clonal complex.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Antibiotic Selection00:57

Antibiotic Selection

Overview